5
Neoadjuvant Therapy
Recommendation 3.1
➤ Patients who are planned for a multimodality approach incorporating
surgery as defined in Recommendation 2.1 should receive systemic
neoadjuvant therapy. (Strong recommendation; EB-B-M)
Recommendation 3.2
➤ Patients with N2 disease who are planned for surgical resection
should receive neoadjuvant chemotherapy or neoadjuvant concurrent
chemoradiation. (Strong recommendation; EB-B-H)
Recommendation 3.3
➤ For patients with resectable superior sulcus disease, neoadjuvant
concurrent chemoradiation should be administered. (Strong
recommendation; EB-B-M)
Treatment
